Abstract
Post-hyaluronic acid filler nodules are an uncommon, unpredictable complication that presents a challenge to clinical therapy. We report a case of a female in her fifties who developed edema and nodules 6 weeks after hyaluronic acid (HA) filler injection. After minimal improvement with oral steroids and intralesional hyaluronidase, a trial of oral abrocitinib was initiated, which yielded significant clinical improvement. Thus, abrocitinib may be a novel therapeutic option for delayed onset nodules following injection of hyaluronic acid.
| Original language | English |
|---|---|
| Pages (from-to) | 1359-1361 |
| Number of pages | 3 |
| Journal | Journal of Drugs in Dermatology |
| Volume | 23 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2024 |